tiprankstipranks
Trending News
More News >
Spyre Therapeutics (SYRE)
NASDAQ:SYRE
US Market
Advertisement

Spyre Therapeutics (SYRE) Ownership - Who Owns Spyre Therapeutics?

Compare
471 Followers

Spyre Therapeutics (SYRE) Ownership Overview

9.65%24.75%0.06%10.67%54.87%
0.06% Other Institutional Investors
10.67% ETFs
54.87% Public Companies and
Individual Investors
The ownership structure of Spyre Therapeutics (SYRE) stock is a mix of institutional, retail, and individual investors. Approximately 35.48% of the company’s stock is owned by Institutional Investors, 9.65% is owned by Insiders, and 54.87% is owned by Public Companies and Individual Investors.
The ownership structure of Spyre Therapeutics (SYRE) stock is a mix of institutional, retail, and individual investors. Approximately 24.81% of the company’s stock is owned by Institutional Investors, 9.65% is owned by Insiders, and 10.67% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Sep 03, 2025
xxxxxxxxxxxxx
$299639

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Jun 30, 2025
xxxxxxxxxxxxx
$6963325
Jun 30, 2025
xxxxxxxxxxxxx
$9186565
Jun 30, 2025
xxxxxxxxxxxxx
$9381743
Jun 30, 2025
xxxxxxxxxxxxx
$22895791

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
4,830,177Insider8.00%71,679,827
4,018,101Institution6.65%59,628,619
2,743,315Institution4.54%40,710,795
2,614,403Institution4.33%38,797,741
2,497,234Institution4.13%37,058,953
2,325,713Institution3.85%34,513,581
2,222,340Institution3.68%32,979,526
2,085,590Institution3.45%30,950,156
1,529,445Institution2.53%22,696,964
1,431,609Institution2.37%21,245,078

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
2,743,315Institution4.54%40,710,795
2,497,234Institution4.13%37,058,953
2,325,713Institution3.85%34,513,581
1,431,609Institution2.37%21,245,078
1,030,368Institution1.71%15,290,661
855,513Institution1.42%12,695,813
690,693Institution1.14%10,249,884
672,555Institution1.11%9,980,716
457,101Institution0.76%6,783,379
288,785Institution0.48%4,285,569

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
1,668,982Institution2.76%28,322,625
1,242,152Institution2.06%18,408,693
646,330Institution1.07%9,591,537
551,977Institution0.91%9,367,050
316,418Institution0.52%4,689,315
299,345Institution0.50%4,436,293
243,345Institution0.40%3,611,240
237,931Institution0.39%4,037,689
142,994Institution0.24%2,119,171
111,966Institution0.19%1,900,063

FAQ

Who Owns Spyre Therapeutics (SYRE)?
According to the latest TipRanks data, approximately 0.06% of the company's stock is held by institutional investors, 9.65% is held by insiders, and 54.87% is held by retail investors.
    What percentage of Spyre Therapeutics (SYRE) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 0.06% of Spyre Therapeutics (SYRE) stock is held by institutional investors.
      What percentage of Spyre Therapeutics (SYRE) stock is held by retail investors?
      According to the latest TipRanks data, approximately 54.87% of Spyre Therapeutics (SYRE) stock is held by retail investors.
        Who owns the most shares of Spyre Therapeutics (SYRE)?
        Fairmount Funds Management LLC owns the most shares of Spyre Therapeutics (SYRE).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis